Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.295 USD | +2.33% | -0.30% | +62.38% |
May. 10 | Leerink Partners Starts Aquestive Therapeutics With Outperform Rating, $8 Price Target | MT |
May. 08 | Transcript : Aquestive Therapeutics, Inc., Q1 2024 Earnings Call, May 08, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+62.38% | 293M | |
+33.76% | 709B | |
+30.55% | 595B | |
-2.32% | 367B | |
+20.47% | 334B | |
+5.14% | 289B | |
+14.19% | 239B | |
+9.05% | 211B | |
-3.80% | 203B | |
+8.36% | 171B |
- Stock Market
- Equities
- AQST Stock
- News Aquestive Therapeutics, Inc.
- Insider Trends: Insider Sales Add to 90-Day Trend at Aquestive Therapeutics